Sequenom, Inc. Announces Date Of Second Quarter 2013 Financial Results And
SAN DIEGO, July 10, 2013
SAN DIEGO, July 10, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative diagnostic testing and genetic analysis
solutions, today announced it will report financial results for the second
quarter of 2013 after closing of the NASDAQ Global Market on Wednesday, July
A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and
other members of senior management will take place on the same day at 5:00 pm
EDT (2:00 pm PDT) and will be webcast live on the Sequenom website.
To access the live teleconference call, dial 800-860-2442 in the U.S. and
Canada, and 412-858-4600 for other international callers. Please specify to
the operator that you would like to join the "Sequenom Second Quarter 2013
Earnings Conference Call." If you are unable to listen to the live webcast, a
teleconference replay will be available through Wednesday, July 31, 2013.
Interested parties can access the replay by dialing 877-344-7529 or
412-317-0088 internationally and entering the conference number 10031140.
The conference call webcast is accessible through the "Investors" section of
the Sequenom website at http://ir.sequenom.com. An online replay will be
available following the initial broadcast until Wednesday, July 31, 2013.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at http://www.sequenom.com to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.
SOURCE Sequenom, Inc.
Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm,
Sequenom, Inc., +1-858-202-9028, email@example.com, Rachel Kennedy, Media
Contact, Chandler Chicco Agency, +1-310-309-1003,
Press spacebar to pause and continue. Press esc to stop.